GlassScriptPhysician profile
Charles S Moreland
NPI 1316027725
$2,519.07
in general payments reported to CMS, 2019-2025
17 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $381 · 2021: $420 · 2022: $349 · 2023: $410 · 2024: $321 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.26 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $494.95 | 2019-2024 | Jornay Pm |
| Corium, LLC | $408.64 | 2021-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $309.50 | 2021-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $256.75 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $205.60 | 2020-2024 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $199.82 | 2020-2022 | |
| Noven Therapeutics, LLC | $140.63 | 2023-2025 | Xelstrym |
| Neos Therapeutics, LP | $123.30 | 2019-2022 | |
| Adlon Therapeutics L.P. | $118.21 | 2019-2021 | |
| Shire North American Group INC | $56.55 | 2019 | |
| Axsome Therapeutics, INC. | $51.42 | 2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $50.73 | 2019-2020 | |
| Rhodes Pharmaceuticals L.P. | $32.91 | 2019 | |
| Arbor Pharmaceuticals, INC. | $19.06 | 2020 | |
| Jazz Pharmaceuticals INC. | $18.05 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $17.47 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.48 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Moreland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.